Bacillus anthracis Edema Toxin Causes Extensive Tissue Lesions and Rapid Lethality in Mice
Authors:
- Georgina F. MillerGMGeorgina F. Miller
- Mahtab MoayeriMMMahtab Moayeri
- Rahul KakkarRKRahul Kakkar
- Yuequan ShenYSYuequan Shen
- Jason F. WigginsJWJason F. Wiggins
- Elizabeth M. McNallyEMElizabeth M. McNally
- Wei-Jen TangWTWei-Jen Tang
- Stephen H. LepplaSLStephen H. Leppla
- 1 November 2005
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 167 (5) , 1309-1320
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (GM53459, GM62548)
- National Institute of Allergy and Infectious Diseases (GM53459, GM62548)
- American Heart Association (GM53459, GM62548)
- Burroughs Wellcome Fund (GM53459, GM62548)
This publication has 58 references indexed in Scilit:
- Mouse Susceptibility to Anthrax Lethal Toxin Is Influenced by Genetic Factors in Addition to Those Controlling Macrophage SensitivityInfection and Immunity, 2004
- Anthrax toxins2004
- Cyclic AMP increases endogenous granulocyte colony‐stimulating factor formation in monocytes and THP‐1 macrophages despite attenuated TNF‐α formationEuropean Journal of Immunology, 2003
- Clinical Features that Discriminate Inhalational Anthrax from Other Acute Respiratory IllnessesClinical Infectious Diseases, 2003
- Neuroendocrine Regulation of ImmunityAnnual Review of Immunology, 2002
- Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United StatesEmerging Infectious Diseases, 2001
- Role of Toxin Functional Domains in Anthrax PathogenesisInfection and Immunity, 2000
- Glucocorticoids and insulin resistance: old hormones, new targetsClinical Science, 1999
- Induction of neutrophilic granulocytosis in mice by administration of purified human native granulocyte colony-stimulating factor (G-CSF)Biochemical and Biophysical Research Communications, 1987
- Purification of Factor I and Recognition of a Third Factor of the Anthrax ToxinMicrobiology, 1961